DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)

13.24 -0.23 (-1.71%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SRPT $13.24 -1.71%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $13.35
Previous Close $13.47
Daily Range $13.09 - $13.56
52-Week Range $11.33 - $40.00
Market Cap $547.0M
P/E Ratio -4.79
Dividend (Yield) $0.00 (0.0%)
Volume 675,305
Average Daily Volume 743,041
Current FY EPS -$4.10




Drug Makers

Sarepta Therapeutics (SRPT) Description

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology. Website:

News & Commentary

Has the Biotech Bubble Already Popped?

Fear about a bubble in biotech is growing, keeping many investors on the sidelines. Is this fear warranted?

Tekmira Up on Ebola Candidate Update from the FDA - Analyst Blog

Sarepta's Long Road Ahead

CNBC's Stock Pops & Drops From April 1: GoPro, Michael Kors, Delta, Sarepta

Sarepta CEO Exits, Eteplirsen Regulatory Filing on Track - Analyst Blog

What Does Sarepta's Big CEO Shakeup Mean?

Morning Market Gainers

Sarepta Therapeutics Inc.'s CEO Exits: Is the Stock Now a Buy?

Sarapeta's CEO abruptly left the company yesterday. With a new face at the helm, can this speculative biotech finally change course?

Sudden Exit of Sarepta CEO Fuels Speculation Soured FDA Relationship to Blame

Sarepta Therapeutics (SRPT) Weak On High Volume Today

See More SRPT News...

SRPT's Top Competitors

SRPT $13.24 (-1.71%)
Current stock: SRPT
AMGN $163.58 (-1.97%)
Current stock: AMGN
GILD $101.38 (-1.90%)
Current stock: GILD
BIIB $419.44 (-2.15%)
Current stock: BIIB